Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Henriksen

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Transfusion|May 1, 1985
Hydroxyethyl starch accentuates von Willebrand's diseaseR G Strauss, D C Stump, R A Henriksen
Transfusion|May 1, 1988
Pentastarch may cause fewer effects on coagulation than hetastarchR G Strauss, C Stansfield, R A Henriksen, et al.
Transfusion|May 1, 1985
Effects of hydroxyethyl starch on fibrinogen, fibrin clot formation, and fibrinolysisR G Strauss, D C Stump, R A Henriksen, et al.
European Journal of Pharmacology|January 5, 2000
Effects of protein kinase C inhibitors on thromboxane production by thrombin-stimulated plateletsG P Samokhin, M R Jirousek, D K Ways, et al.
American Journal of Clinical Pathology|April 1, 1979
An intrinsic coagulation pathway inhibitor in a 3-year-old childD W Beck, R G Strauss, C T Kisker, et al.
The Journal of Clinical Investigation|November 1, 1980
Identification of a congenital dysthrombin, thrombin QuickR A Henriksen, W G Owen, M E Nesheim, et al.
Mayo Clinic Proceedings|January 1, 1978
Prothrombin Quick. A newly identified dysprothrombinemiaC A Owen, R A Henriksen, F C McDuffie, et al.
Biochemistry|July 2, 1991
Interaction of hirudin with the dysthrombins Quick I and IIS R Stone, T Schmitz, R A Henriksen, et al.
Transfusion|July 1, 1985
Effects of hydroxyethyl starch on blood coagulation, particularly factor VIIID C Stump, R G Strauss, R A Henriksen, et al.
Blood|February 1, 1981
The factor VIII:C level is lower in daughters of hemophilia A subjectsR A Henriksen, C T Kisker, P A Lachenbruch, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Transfusion|May 1, 1985
Hydroxyethyl starch accentuates von Willebrand's diseaseR G Strauss, D C Stump, R A Henriksen
Transfusion|May 1, 1988
Pentastarch may cause fewer effects on coagulation than hetastarchR G Strauss, C Stansfield, R A Henriksen, et al.
Transfusion|May 1, 1985
Effects of hydroxyethyl starch on fibrinogen, fibrin clot formation, and fibrinolysisR G Strauss, D C Stump, R A Henriksen, et al.
European Journal of Pharmacology|January 5, 2000
Effects of protein kinase C inhibitors on thromboxane production by thrombin-stimulated plateletsG P Samokhin, M R Jirousek, D K Ways, et al.
American Journal of Clinical Pathology|April 1, 1979
An intrinsic coagulation pathway inhibitor in a 3-year-old childD W Beck, R G Strauss, C T Kisker, et al.
The Journal of Clinical Investigation|November 1, 1980
Identification of a congenital dysthrombin, thrombin QuickR A Henriksen, W G Owen, M E Nesheim, et al.
Mayo Clinic Proceedings|January 1, 1978
Prothrombin Quick. A newly identified dysprothrombinemiaC A Owen, R A Henriksen, F C McDuffie, et al.
Biochemistry|July 2, 1991
Interaction of hirudin with the dysthrombins Quick I and IIS R Stone, T Schmitz, R A Henriksen, et al.
Transfusion|July 1, 1985
Effects of hydroxyethyl starch on blood coagulation, particularly factor VIIID C Stump, R G Strauss, R A Henriksen, et al.
Blood|February 1, 1981
The factor VIII:C level is lower in daughters of hemophilia A subjectsR A Henriksen, C T Kisker, P A Lachenbruch, et al.
Pageof 3